DIGITALDX
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Jean Machart
      • Laura Mezey
      • Ramin Khaksar
      • Alissa Hsu Lynch
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
      • Mrunalini Parvataneni
      • Doug Ross
      • Sheila McGinley-Graziosi
      • Scott Ashworth
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video
Picture
Michael Doherty, BSc
Picture
  • Chief Regulatory Officer: EQRx
  • Board of Directors: Multiply Labs - a company developing robotics for the personalization of combination prescriptions and robotics in the manufacture of advanced medical technologies
  • Board of Directors: Genomill (NGS)
  • Strategic Adviser for Stealth company in NGS, VectivBio (therapeutics company in rare diseases), Highlight Therapeutics (Oncology), Personalis (Cancer genomics), Somalogic (Proteomics), Parithera (Single-cell applications), Oncoustics (AI-driven diagnostics
  • Former Global Head, Pharma Regulatory Affairs, Hoffmann La-Roche Ltd., Basel/Genentech, San Francisco​
Michael Doherty is a highly experienced executive in both the pharmaceutical and diagnostics industries, at the forefront of precision medicine. He has a deep knowledge of regulatory affairs and product development and recently achieved ground-breaking approval of the first comprehensive NGS panel for Foundation Medicine (F1CDx) which combines genomic analyses with companion diagnostics.
Driven by innovation, Doherty was given the responsibility inside Roche and Genentech to build and lead an Innovation Function in Product Development with the task of disrupting the drug development process.
​

He also led Roche's Global Regulatory Affairs function through the critical growth years, where Roche was able to launch the number one oncology portfolio with a franchise of monoclonal antibodies and targeted medicines. Doherty was a member of the Roche portfolio committee from 2002 to 2016.
He received his BSc in Physiology and Biochemistry with a subsidiary in Chemistry from the University of Reading, U.K., a Fellowship of the Institute of Medical Laboratory Science from Manchester Metropolitan University, U.K., and a Diploma in Management Studies from the University of Portsmouth, U.K.
Disclaimer
Terms & Conditions
Privacy Policy
Investment Inquiries
Contact
Picture
Picture
Picture
 Copyright © 2022 All Rights Reserved
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Jean Machart
      • Laura Mezey
      • Ramin Khaksar
      • Alissa Hsu Lynch
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
      • Mrunalini Parvataneni
      • Doug Ross
      • Sheila McGinley-Graziosi
      • Scott Ashworth
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video